SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 773.78 millions for the September 2024 quarter as against Rs. 965.76 millions during the year-ago period.The Company to register a -50.34%  fall in the net profit for the quarter ended September 2024.Operating Profit reported a sharp decline to 151.81 millions from 274.03 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 773.78 965.76 -19.88 1633.35 1819.25 -10.22 3654.69 3115.29 17.31
Other Income 16.55 7.85 110.83 555.31 520.34 6.72 588.09 98.08 499.60
PBIDT 151.81 274.03 -44.60 899.78 1034.29 -13.01 1639.95 846.96 93.63
Interest 0.76 0.33 130.30 0.98 0.68 44.12 1.57 1.35 16.30
PBDT 151.05 273.70 -44.81 898.80 1033.61 -13.04 1448.90 845.61 71.34
Depreciation 27.84 26.09 6.71 54.03 51.16 5.61 108.98 102.83 5.98
PBT 123.21 247.61 -50.24 844.77 982.45 -14.01 1339.92 742.78 80.39
TAX 31.95 63.83 -49.95 82.95 123.80 -33.00 258.69 187.51 37.96
Deferred Tax 1.29 -2.32 -155.60 2.83 -3.00 -194.33 -10.82 4.97 -317.71
PAT 91.26 183.78 -50.34 761.82 858.65 -11.28 1081.23 555.27 94.72
Equity 223.65 223.65 0.00 223.65 223.65 0.00 223.65 223.65 0.00
PBIDTM(%) 19.62 28.37 -30.86 55.09 56.85 -3.10 44.87 27.19 65.05

Advanced Enzyme Share Price

298.60 -0.40 (-0.13%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×